Preparation, crystallization and preliminary X-ray analysis of a complex between thePlasmodium vivaxsexual stage 25 kDa protein Pvs25 and a malaria transmission-blocking antibody Fab fragment

2004 ◽  
Vol 60 (11) ◽  
pp. 2054-2057 ◽  
Author(s):  
Ajay K. Saxena ◽  
Kavita Singh ◽  
Carole A. Long ◽  
David N. Garboczi
2019 ◽  
Vol 10 (1) ◽  
Author(s):  
Brandon McLeod ◽  
Kazutoyo Miura ◽  
Stephen W. Scally ◽  
Alexandre Bosch ◽  
Ngan Nguyen ◽  
...  

Abstract Transmission-blocking vaccines have the potential to be key contributors to malaria elimination. Such vaccines elicit antibodies that inhibit parasites during their development in Anopheles mosquitoes, thus breaking the cycle of transmission. To date, characterization of humoral responses to Plasmodium falciparum transmission-blocking vaccine candidate Pfs25 has largely been conducted in pre-clinical models. Here, we present molecular analyses of human antibody responses generated in a clinical trial evaluating Pfs25 vaccination. From a collection of monoclonal antibodies with transmission-blocking activity, we identify the most potent transmission-blocking antibody yet described against Pfs25; 2544. The interactions of 2544 and three other antibodies with Pfs25 are analyzed by crystallography to understand structural requirements for elicitation of human transmission-blocking responses. Our analyses provide insights into Pfs25 immunogenicity and epitope potency, and detail an affinity maturation pathway for a potent transmission-blocking antibody in humans. Our findings can be employed to guide the design of improved malaria transmission-blocking vaccines.


1989 ◽  
Vol 209 (1) ◽  
pp. 177-178 ◽  
Author(s):  
Danièle Altschuh ◽  
Hans-Peter Kocher ◽  
Valérie F.J. Quesniaux ◽  
Doris Schmitter ◽  
Marc H.V. Van Regenmortel ◽  
...  
Keyword(s):  

Parasitology ◽  
1994 ◽  
Vol 109 (1) ◽  
pp. 11-17 ◽  
Author(s):  
G. R. R. Ranawaka ◽  
A. R. Alejo-Blanco ◽  
R. E. Sinden

SUMMARYThe transmission-blocking monoclonal antibody 13.1, which recognizes the ookinete surface antigen Pbs21 ofPlasmodium berghei, and an IgG2a isotype control antibody 26.37 were purified by caprylic acid and ammonium sulphate precipitation. Fab fragments were prepared by papain digestion. IgG but not Fab from antibody 13.1 reduced ookinete formation byP. bergheiin culture by as much as 94% at a concentration of 100 μg/ml. There was little difference in antibody efficacy in the range 6·25–400 μg/ml in this assay. The parasite was most sensitive to antibody activity in the first 6–9 h of culture, i.e. the gamete/zygote and early retort stages. Peripheral blood leucocytes (PBL) were essential to achieve maximal inhibition by mAb 13.1 (activity was abrogated totally if PBL were removed). Together the data suggest that one of the mechanisms of action of this antibody is antibody-mediated PBL killing. Phagocytosis of parasites was noted in these experiments in all cultures. We have not attempted in this study to distinguish between Fc-mediated opsonization, as opposed to antibody-dependent cellular cytotoxicity.


2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Anais Bompard ◽  
Dari F. Da ◽  
Rakiswendé S. Yerbanga ◽  
Sumi Biswas ◽  
Melissa Kapulu ◽  
...  

2019 ◽  
Vol 10 ◽  
Author(s):  
Michael Delves ◽  
M. Jose Lafuente-Monasterio ◽  
Leanna Upton ◽  
Andrea Ruecker ◽  
Didier Leroy ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document